TW287162B - - Google Patents

Info

Publication number: TW287162B
Authority: TW; Taiwan
Prior art keywords: neurosis; cataract; halogen; represents hydrogen; salt
Prior art date: 1993-01-06

Application number

TW083100332A

Other languages

English (en)

Chinese (zh)

Original Assignee

Green Cross Corp

Senju Pharma Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-01-06

Filing date

1994-01-17

Publication date

1996-10-01

1994-01-17 Application filed by Green Cross Corp, Senju Pharma Co filed Critical Green Cross Corp

1996-10-01 Application granted granted Critical

1996-10-01 Publication of TW287162B publication Critical patent/TW287162B/zh

Links

208000002177 Cataract Diseases 0.000 abstract 2
206010029333 Neurosis Diseases 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
229910052739 hydrogen Inorganic materials 0.000 abstract 2
239000001257 hydrogen Substances 0.000 abstract 2
208000015238 neurotic disease Diseases 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
GQOJGBVTUSRBPQ-UHFFFAOYSA-N 2-quinolin-3-ylacetic acid Chemical class C1=CC=CC2=CC(CC(=O)O)=CN=C21 GQOJGBVTUSRBPQ-UHFFFAOYSA-N 0.000 abstract 1
229940118148 Aldose reductase inhibitor Drugs 0.000 abstract 1
208000028006 Corneal injury Diseases 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
208000017442 Retinal disease Diseases 0.000 abstract 1
206010038923 Retinopathy Diseases 0.000 abstract 1
239000003288 aldose reductase inhibitor Substances 0.000 abstract 1
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
206010012601 diabetes mellitus Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical compound OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 abstract 1
150000002431 hydrogen Chemical class 0.000 abstract 1
208000017169 kidney disease Diseases 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Ophthalmology & Optometry (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Quinoline Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

TW083100332A 1993-01-06 1994-01-17 TW287162B (2)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP01589993A JP3195455B2 (ja)	1993-01-06	1993-01-06	キノリン−３−酢酸誘導体、その製造法と用途

Publications (1)

Publication Number	Publication Date
TW287162B true TW287162B (2)	1996-10-01

Family

ID=11901633

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW083100332A TW287162B (2)	1993-01-06	1994-01-17

Country Status (12)

Country	Link
US (1)	US5543420A (2)
EP (1)	EP0633261B1 (2)
JP (1)	JP3195455B2 (2)
KR (1)	KR950700289A (2)
CN (1)	CN1102040A (2)
AT (1)	ATE179172T1 (2)
AU (1)	AU667426B2 (2)
CA (1)	CA2131370A1 (2)
DE (1)	DE69417957T2 (2)
ES (1)	ES2130403T3 (2)
TW (1)	TW287162B (2)
WO (1)	WO1994015934A1 (2)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5700819A (en) *	1994-11-29	1997-12-23	Grelan Pharmaceutical Co., Ltd.	2-substituted benzothiazole derivatives and prophylactic and therapeutic agents for the treatment of diabetic complications
TNSN99224A1 (fr)	1998-12-01	2005-11-10	Inst For Pharm Discovery Inc	Methodes de reduction des niveaux de glucose et triglyceride en serum et pour suppression de l'antigenese utilisant les acides la indolealkanoique
CN101058558B (zh) *	2007-05-28	2013-04-10	沈阳药科大学	具有醛糖还原酶抑制活性的4-氧代-1(4h)-喹啉羧酸类化合物、组合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1986007056A1 (en) *	1985-05-21	1986-12-04	Pfizer Inc.	Hypoglycemic thiazolidinediones
JPS63270678A (ja) *	1987-04-30	1988-11-08	Mitsui Petrochem Ind Ltd	新規含窒素化合物
US5143930A (en) *	1990-02-07	1992-09-01	Sankyo Company, Limited	Thiazolidine derivatives with anti-diabetic activity, their preparation and their use
TW202450B (2) *	1991-06-26	1993-03-21	Dainippon Pharmaceutical Co
US5262433A (en) *	1991-08-06	1993-11-16	Wakamoto Pharmaceutical Co., Ltd.	Tetrazoleacetic acid derivatives and method of aldose reductase inhibition therewith

1993
- 1993-01-06 JP JP01589993A patent/JP3195455B2/ja not_active Expired - Fee Related
1994
- 1994-01-06 EP EP94904000A patent/EP0633261B1/en not_active Expired - Lifetime
- 1994-01-06 AU AU58233/94A patent/AU667426B2/en not_active Ceased
- 1994-01-06 ES ES94904000T patent/ES2130403T3/es not_active Expired - Lifetime
- 1994-01-06 US US08/295,876 patent/US5543420A/en not_active Expired - Fee Related
- 1994-01-06 WO PCT/JP1994/000007 patent/WO1994015934A1/ja not_active Ceased
- 1994-01-06 CN CN94190041A patent/CN1102040A/zh active Pending
- 1994-01-06 CA CA002131370A patent/CA2131370A1/en not_active Abandoned
- 1994-01-06 AT AT94904000T patent/ATE179172T1/de not_active IP Right Cessation
- 1994-01-06 DE DE69417957T patent/DE69417957T2/de not_active Expired - Fee Related
- 1994-01-17 TW TW083100332A patent/TW287162B/zh active
- 1994-09-06 KR KR1019940703121A patent/KR950700289A/ko not_active Abandoned

Also Published As

Publication number	Publication date
AU5823394A (en)	1994-08-15
EP0633261A4 (en)	1995-04-12
CA2131370A1 (en)	1994-07-21
US5543420A (en)	1996-08-06
JPH06199851A (ja)	1994-07-19
KR950700289A (ko)	1995-01-16
WO1994015934A1 (fr)	1994-07-21
JP3195455B2 (ja)	2001-08-06
ES2130403T3 (es)	1999-07-01
AU667426B2 (en)	1996-03-21
DE69417957T2 (de)	1999-09-16
CN1102040A (zh)	1995-04-26
DE69417957D1 (de)	1999-05-27
EP0633261A1 (en)	1995-01-11
ATE179172T1 (de)	1999-05-15
EP0633261B1 (en)	1999-04-21

Publication	Publication Date	Title
PT798295E (pt)	2003-07-31	Novo derivado de amidinonaftilo ou sal deste
ZA95631B (en)	1995-10-05	Prolineamide derivatives
FI943948A0 (fi)	1994-08-26	Heterosykliset hiilihappojohdannaiset
NO904202D0 (no)	1990-09-27	Terapeutisk aktive bifenylmetanderivater og fremgangsmaatefor deres fremstilling.
AU5513996A (en)	1996-11-18	1,4-di-substituted piperidine derivatives
AU2231797A (en)	1997-09-22	Novel iridoid derivatives and a vascularization inhibitor having for its active ingredient said derivative
EP1666041A3 (en)	2008-04-02	Xanthine derivatives for treating neurodegenerative disorders
EP0412940A3 (en)	1991-10-23	Hydantoin or imidazolidinetrione derivatives for the prevention or treatment of renal failure
TW245717B (2)	1995-04-21
AU5754294A (en)	1994-09-08	Use of a pregnane derivative
AU667426B2 (en)	1996-03-21	Quinoline-3-acetic acid derivative, process for producing the same, and use thereof
AU2692792A (en)	1993-05-21	Oxazolidone derivative
EP0659763A3 (en)	1995-12-20	Esters of quinoline-carboxylic acids with 21-pregnane derivatives and bactericidal and anti-inflammatory compositions containing them.
AU695907B2 (en)	1998-08-27	Pharmaceutical composition for prophylaxis and treatment of type I allergic diseases
AU1823995A (en)	1995-12-21	Arteriosclerosis depressant
AU7238994A (en)	1995-04-03	Succinamic acid compound, process for producing the same, and use thereof
DK0556813T3 (da)	1998-08-10	Amfotere tricykliske forbindelser som antihistaminske og antiallergiske midler
AU7424394A (en)	1995-04-13	3- or 4-glycosyloxybenzopyran derivatives and antiallergic agents containing the derivatives as active ingredients
PL354619A1 (en)	2004-02-09	Benzamidine derivatives
AU4397197A (en)	1998-04-17	Subepithelial turbidity inhibitor
GR3022450T3 (en)	1997-04-30	Piperidine derivatives with antihistaminic and antileukohienic activity.
HU9602534D0 (en)	1996-11-28	Use of biphenyl methyl imidazole derivatives for producing pharmaceutical compositions having ocular tension derpessant activity
ATE124217T1 (de)	1995-07-15	Vorbeugende/therapeutische zusammensetzung für die pleuropneumonie des schweins.
PL147875B1 (en)	1989-08-31	Method of obtaining derivatives of tetracyclic spirolohydantoine
WO1993005044A1 (fr)	1993-03-18	Derive de pyrazolotriazole